| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04378647 | BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant | Hodgkin Lymphoma, Adult | Recruiting |
| NCT07126236 | Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of… | Large B Cell Lymphoma | Recruiting |
| NCT07254754 | Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse… | DIFFUSE LARGE B-CELL LYMPHOMA | Recruiting |
| NCT07285590 | Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in… | Mantle Cell Lymphoma (MCL) | Recruiting |
| NCT02682641 | Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL | Mantle Cell Lymphoma | Active, Not Recruiting |
| Not specified | |||
| NCT07624838 | Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+… | CD30-Positive Peripheral T-Cell Lymphoma | Recruiting |